Gemifloxacin as first line treatment for community acquired pneumonia in mexico- A cost—effectiveness study
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.414
https://www.valueinhealthjournal.com/article/S1098-3015(13)00485-3/fulltext
Section Title :
Infection
Section Order :
1455
First Page :
A89
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00485-3&doi=10.1016/j.jval.2013.03.414